Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Why Femasys Shares Are Trading Higher By Over 200%; Here Are 20 Stocks Moving Premarket

Published 26/09/2023, 13:05
© Reuters. Why Femasys Shares Are Trading Higher By Over 200%; Here Are 20 Stocks Moving Premarket

Benzinga - by Lisa Levin, Benzinga Editor.

Gainers

  • Femasys Inc. (NASDAQ: FEMY) shares rose 201% to $1.00 in pre-market trading after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment.
  • Tharimmune Inc (NASDAQ: THAR) shares rose 101.4% to $0.4450 in pre-market trading after falling around 5% on Monday.
  • Infobird Co., Ltd (NASDAQ: IFBD) shares gained 31.1% to $0.1709 in pre-market trading. Infobird recently announced receipt of delinquency notification letter from the Nasdaq.
  • Avalo Therapeutics, Inc. (NASDAQ: AVTX) gained 19.3% to $0.1945 in pre-market trading after jumping over 36% on Monday. The company recently announced the sale of its assets relating to AVTX-801 (D-galactose), AVTX-802 (D-mannose) and AVTX-803 (L-fucose).
  • Akumin Inc. (NASDAQ: AKU) shares rose 18.4% to $0.1670 in pre-market trading.
  • NexImmune, Inc. (NASDAQ: NEXI) shares surged 17% to $0.2399 in pre-market trading.
  • Precision BioSciences, Inc. (NASDAQ: DTIL) rose 16.1% to $0.4280 in pre-market trading.
  • Adaptive Biotechnologies Corporation (NASDAQ: ADPT) shares climbed 13.8% to $5.78 in pre-market trading. Adaptive recently announced the launch of Epic integration for clonoSEQ.
  • E-Home Household Service Holdings Limited (NASDAQ: EJH) shares jumped 11.7% to $1.05 in pre-market trading.
  • Blue Star Foods Corp. (NASDAQ: BSFC) rose 10.3% to $0.2560 in pre-market trading after dipping 20% on Monday.
Losers
  • TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell 67.8% to $0.8195 in pre-market trading after the company priced its $8 million public offering of 15.7 million shares at $0.51 per share.
  • Murphy Canyon Acquisition Corp. (NYSE: CDT) fell 18.1% to $8.50 in pre-market trading after dipping 38% on Monday.
  • Jet.AI Inc. (NASDAQ: JTAI) shares fell 17.6% to $2.53 in pre-market trading after surging 25% on Monday.
  • MSP Recovery, Inc. (NASDAQ: LIFW) shares fell 13.5% to $0.1751 in pre-market trading after declining around 15% on Monday.
  • Biophytis S.A. (NASDAQ: BPTS) fell 13.2% to $1.38 in pre-market trading. Biophytis shares jumped over 72% on Monday after the company and Skyepharma announced a partnership agreement for the production of regulatory batches of Sarconeos (BIO101) for severe forms of Covid-19.
  • Polished.com Inc. (NYSE: POL) fell 12.4% to $0.1086 in pre-market trading after surging 40% on Monday.
  • Sacks Parente Golf, Inc. (NASDAQ: SPGC) fell 11.7% to $1.20 in pre-market trading. The company recently posted a narrower second-quarter loss.
  • FaZe Holdings Inc. (NASDAQ: FAZE) shares fell 10.4% to $0.1720 in pre-market trading after jumping 25% on Monday.
  • PaxMedica, Inc. (NASDAQ: PXMD) fell 10% to $0.28 in pre-market trading after gaining 5% on Monday.
  • Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) fell 9.8% to $0.0833 in pre-market after declining over 4% on Monday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.